Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription

Articles published in Gut

Retrieve available abstracts of 67 articles:
HTML format
Text format

Single Articles

    August 2018
  1. STRNAD P, Buch S, Hamesch K, Fischer J, et al
    Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
    Gut. 2018 Aug 1. pii: gutjnl-2018-316228. doi: 10.1136/gutjnl-2018-316228.
    PubMed     Text format     Abstract available

    March 2018
  2. LUETKENS JA, Klein S, Traeber F, Schmeel FC, et al
    Quantitative liver MRI including extracellular volume fraction for non-invasive quantification of liver fibrosis: a prospective proof-of-concept study.
    Gut. 2018;67:593-594.
    PubMed     Text format    

    February 2018
  3. RENZULLI M, Biselli M, Brocchi S, Granito A, et al
    New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Gut. 2018 Feb 3. pii: gutjnl-2017-315384. doi: 10.1136/gutjnl-2017-315384.
    PubMed     Text format     Abstract available

  4. MURATA K, Asano M, Matsumoto A, Sugiyama M, et al
    Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
    Gut. 2018;67:362-371.
    PubMed     Text format     Abstract available

    September 2017
  5. LV Y, Qi X, He C, Wang Z, et al
    Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Gut. 2017 Sep 28. pii: gutjnl-2017-314634. doi: 10.1136/gutjnl-2017-314634.
    PubMed     Text format     Abstract available

  6. Erratum: The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Gut. 2017;66:1730.
    PubMed     Text format    

  7. MAGDALENO F, Trebicka J
    Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression.
    Gut. 2017;66:1540-1541.
    PubMed     Text format    

    August 2017
  8. PIANO S, Bartoletti M, Tonon M, Baldassarre M, et al
    Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections.
    Gut. 2017 Aug 31. pii: gutjnl-2017-314324. doi: 10.1136/gutjnl-2017-314324.
    PubMed     Text format     Abstract available

  9. ZHANG W, Sun M, Chen G, An Y, et al
    Reassessment of gamma-glutamyl transpeptidase to platelet ratio (GPR): a large-sample, dynamic study based on liver biopsy in a Chinese population with chronic hepatitis B virus (HBV) infection.
    Gut. 2017 Aug 16. pii: gutjnl-2017-313896. doi: 10.1136/gutjnl-2017-313896.
    PubMed     Text format    

    July 2017
  10. ALBANO E, Stickel F
    Targeting toll-like receptor 7/8 improves host anti-infective response in alcoholic cirrhosis.
    Gut. 2017 Jul 7. pii: gutjnl-2017-314437. doi: 10.1136/gutjnl-2017-314437.
    PubMed     Text format    

  11. HARDY T, Zeybel M, Day CP, Dipper C, et al
    Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
    Gut. 2017;66:1321-1328.
    PubMed     Text format     Abstract available

  12. MANDORFER M, Peck-Radosavljevic M, Reiberger T
    Prevention of progression from small to large varices: are we there yet? An updated meta-analysis.
    Gut. 2017;66:1347-1349.
    PubMed     Text format    

    June 2017
  13. ROLAS L, Boussif A, Weiss E, Letteron P, et al
    NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation.
    Gut. 2017 Jun 10. pii: gutjnl-2016-313443. doi: 10.1136/gutjnl-2016-313443.
    PubMed     Text format     Abstract available

  14. BAJAJ JS, Liu EJ, Kheradman R, Fagan A, et al
    Fungal dysbiosis in cirrhosis.
    Gut. 2017 Jun 3. pii: gutjnl-2016-313170. doi: 10.1136/gutjnl-2016-313170.
    PubMed     Text format     Abstract available

  15. ARRIAZU E, Ge X, Leung TM, Magdaleno F, et al
    Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
    Gut. 2017;66:1123-1137.
    PubMed     Text format     Abstract available

  16. SCHIAVON LL, Narciso-Schiavon JL, Ferraz MLG, Silva AEB, et al
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) in HBV patients: just adding up?
    Gut. 2017;66:1169-1170.
    PubMed     Text format    

    May 2017
  17. BREITKOPF-HEINLEIN K, Meyer C, Konig C, Gaitantzi H, et al
    BMP-9 interferes with liver regeneration and promotes liver fibrosis.
    Gut. 2017;66:939-954.
    PubMed     Text format     Abstract available

    February 2017
  18. ARNOLD F, Patch D, Yu D, Westbrook RH, et al
    When banding fails; investigation hails.
    Gut. 2017;66:322.
    PubMed     Text format    

    January 2017
  19. MENARD A, Aherfi S, Mokhtari S, Dhiver C, et al
    Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313431. doi: 10.1136/gutjnl-2016-313431.
    PubMed     Text format    

  20. IKENAGA N, Peng ZW, Vaid KA, Liu SB, et al
    Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Gut. 2017 Jan 10. pii: gutjnl-2016-312473. doi: 10.1136/gutjnl-2016-312473.
    PubMed     Text format     Abstract available

  21. AUGUSTIN S, Pons M, Genesca J
    Ruling in and ruling out with elastography in compensated advanced chronic liver disease.
    Gut. 2017;66:197-198.
    PubMed     Text format    

  22. LEMOINE M, Thursz M, Mallet V, Shimakawa Y, et al
    Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference.
    Gut. 2017;66:195-196.
    PubMed     Text format    

    September 2016
  23. KUTTKAT N, Mohs A, Ohl K, Hooiveld G, et al
    Hepatic overexpression of cAMP-responsive element modulator alpha induces a regulatory T-cell response in a murine model of chronic liver disease.
    Gut. 2016 Sep 29. pii: gutjnl-2015-311119. doi: 10.1136/gutjnl-2015-311119.
    PubMed     Text format     Abstract available

  24. DAHEIM M, Lang S, Goeser T, Steffen HM, et al
    Real-world risk score for hepatocellular carcinoma risk prediction in CHBV: a validation outside of Asia.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312993. doi: 10.1136/gutjnl-2016-312993.
    PubMed     Text format    

    August 2016

  25. Erratum: Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.
    Gut. 2016;65:1394.
    PubMed     Text format    

    July 2016
  26. HACKSTEIN CP, Assmus LM, Welz M, Klein S, et al
    Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis.
    Gut. 2016 Jul 18. pii: gutjnl-2015-311224. doi: 10.1136/gutjnl-2015-311224.
    PubMed     Text format     Abstract available

  27. WELZEL TM, Nelson DR, Morelli G, Di Bisceglie A, et al
    Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.
    Gut. 2016 Jul 13. pii: gutjnl-2016-311609. doi: 10.1136/gutjnl-2016-311609.
    PubMed     Text format     Abstract available

  28. SHIMAKAWA Y, Bonnard P, El Kassas M, Abdel-Hamid M, et al
    Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio to predict liver fibrosis in Egyptian patients with HCV genotype 4.
    Gut. 2016 Jul 7. pii: gutjnl-2016-312326. doi: 10.1136/gutjnl-2016-312326.
    PubMed     Text format    

    June 2016
  29. BHARDWAJ A, Kedarisetty CK, Vashishtha C, Bhadoria AS, et al
    Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial.
    Gut. 2016 Jun 13. pii: gutjnl-2016-311735. doi: 10.1136/gutjnl-2016-311735.
    PubMed     Text format     Abstract available

  30. STICKEL F, Dubuquoy L
    MicroRNA in alcoholic hepatitis: implications for pathophysiology and treatment.
    Gut. 2016 Jun 1. pii: gutjnl-2016-312101. doi: 10.1136/gutjnl-2016-312101.
    PubMed     Text format    

    May 2016
  31. NJEI B, McCarty TR, Garcia-Tsao G
    Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters.
    Gut. 2016 May 20. pii: gutjnl-2016-312129. doi: 10.1136/gutjnl-2016-312129.
    PubMed     Text format    

    April 2016
  32. O'BRIEN A, China L
    Is human albumin solution really the best resuscitation fluid for patients with advanced cirrhosis?
    Gut. 2016 Apr 27. pii: gutjnl-2016-311999. doi: 10.1136/gutjnl-2016-311999.
    PubMed     Text format    

  33. JANSEN C, Bogs C, Krag A, Francque S, et al
    Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease.
    Gut. 2016 Apr 27. pii: gutjnl-2016-311955. doi: 10.1136/gutjnl-2016-311955.
    PubMed     Text format    

  34. BOYD A, Bottero J, Lacombe K
    The gamma-glutamyl transpeptidase-to-platelet ratio as a predictor of liver fibrosis in patients co-infected with HBV and HIV.
    Gut. 2016;65:718-20.
    PubMed     Text format    

    March 2016
  35. BRITO-AZEVEDO A, Perez RM, Coelho HS, Fernandes ES, et al
    Propranolol improves endothelial dysfunction in advanced cirrhosis: the 'endothelial exhaustion' hypothesis.
    Gut. 2016 Mar 16. pii: gutjnl-2016-311696. doi: 10.1136/gutjnl-2016-311696.
    PubMed     Text format    

  36. KALAMBOKIS GN, Baltayiannis G, Christou L, Christodoulou D, et al
    Red signs and not severity of cirrhosis should determine non-selective beta-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use.
    Gut. 2016 Mar 2. pii: gutjnl-2016-311527. doi: 10.1136/gutjnl-2016-311527.
    PubMed     Text format    

  37. ZHAO XL, Yang JR, Lin SZ, Ma H, et al
    Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.
    Gut. 2016;65:502-11.
    PubMed     Text format     Abstract available

  38. ICHOU L, Carbonell N, Rautou PE, Laurans L, et al
    Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis.
    Gut. 2016;65:536-8.
    PubMed     Text format    

    February 2016
  39. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.
    Gut. 2016 Feb 26. pii: gutjnl-2016-311452. doi: 10.1136/gutjnl-2016-311452.
    PubMed     Text format    

  40. JANSEN C, Bogs C, Verlinden W, Thiele M, et al
    Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study.
    Gut. 2016 Feb 19. pii: gutjnl-2016-311536. doi: 10.1136/gutjnl-2016-311536.
    PubMed     Text format    

    January 2016
  41. STOCKDALE AJ, Phillips RO, Geretti AM
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptida
    Gut. 2016 Jan 4. pii: gutjnl-2015-311133. doi: 10.1136/gutjnl-2015-311133.
    PubMed     Text format    

    December 2015
  42. HU HH, Liu J, Lin YL, Luo WS, et al
    The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Gut. 2015 Dec 7. pii: gutjnl-2015-310686. doi: 10.1136/gutjnl-2015-310686.
    PubMed     Text format     Abstract available

    October 2015
  43. NAHON P, Lescat M, Layese R, Bourcier V, et al
    Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
    Gut. 2015 Oct 28. pii: gutjnl-2015-310275. doi: 10.1136/gutjnl-2015-310275.
    PubMed     Text format     Abstract available

    September 2015
  44. KLEIN S, Rick J, Lehmann J, Schierwagen R, et al
    Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Gut. 2015 Sep 17. pii: gutjnl-2015-309600. doi: 10.1136/gutjnl-2015-309600.
    PubMed     Text format     Abstract available

  45. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
    Gut. 2015 Sep 14. pii: gutjnl-2015-310593. doi: 10.1136/gutjnl-2015-310593.
    PubMed     Text format    

    August 2015
  46. ZEISEL MB, Lucifora J, Mason WS, Sureau C, et al
    Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
    Gut. 2015;64:1314-26.
    PubMed     Text format     Abstract available

    July 2015
  47. COOMBES JD, Swiderska-Syn M, Dolle L, Reid D, et al
    Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.
    Gut. 2015;64:1120-31.
    PubMed     Text format     Abstract available

    June 2015
  48. LEMOINE M, Shimakawa Y, Nayagam S, Khalil M, et al
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Gut. 2015 Jun 24. pii: gutjnl-2015-309260. doi: 10.1136/gutjnl-2015-309260.
    PubMed     Text format     Abstract available

  49. ZHANG DY, Goossens N, Guo J, Tsai MC, et al
    A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
    Gut. 2015 Jun 4. pii: gutjnl-2015-309655. doi: 10.1136/gutjnl-2015-309655.
    PubMed     Text format     Abstract available

  50. BEDRELI S, Sowa JP, Gerken G, Saner FH, et al
    Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis.
    Gut. 2015 Jun 3. pii: gutjnl-2015-309922. doi: 10.1136/gutjnl-2015-309922.
    PubMed     Text format    

    May 2015
  51. TAKUMA Y, Nouso K, Morimoto Y, Tomokuni J, et al
    Prediction of oesophageal variceal bleeding by measuring spleen stiffness in patients with liver cirrhosis.
    Gut. 2015 May 25. pii: gutjnl-2015-309741. doi: 10.1136/gutjnl-2015-309741.
    PubMed     Text format    

  52. LEE YA, Wallace MC, Friedman SL
    Pathobiology of liver fibrosis: a translational success story.
    Gut. 2015;64:830-41.
    PubMed     Text format     Abstract available

    April 2015
  53. MOREAU R
    Stimulating hepatocyte renewal: a new paradigm for the treatment of severe alcoholic hepatitis unresponsive to corticosteroids?
    Gut. 2015 Apr 3. pii: gutjnl-2015-309545. doi: 10.1136/gutjnl-2015-309545.
    PubMed     Text format    

  54. PLOMPEN EP, Hansen BE, Schouten JN, Darwish Murad S, et al
    Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study.
    Gut. 2015;64:692-4.
    PubMed     Text format    

    March 2015
  55. GIANNINI EG, Savarino V
    An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic HCV infection and advanced liver disease.
    Gut. 2015 Mar 24. pii: gutjnl-2015-309440. doi: 10.1136/gutjnl-2015-309440.
    PubMed     Text format    

  56. DUBUQUOY L, Louvet A, Lassailly G, Truant S, et al
    Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.
    Gut. 2015 Mar 2. pii: gutjnl-2014-308410. doi: 10.1136/gutjnl-2014-308410.
    PubMed     Text format     Abstract available

    February 2015
  57. MORALES-IBANEZ O, Affo S, Rodrigo-Torres D, Blaya D, et al
    Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis.
    Gut. 2015 Feb 4. pii: gutjnl-2014-307979. doi: 10.1136/gutjnl-2014-307979.
    PubMed     Text format     Abstract available

    January 2015
  58. TREBICKA J, Schierwagen R
    Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension.
    Gut. 2015 Jan 16. pii: gutjnl-2014-308800. doi: 10.1136/gutjnl-2014-308800.
    PubMed     Text format    

    December 2014
  59. JOOSSE ME, Schipper ME, Libbrecht L, Buuren HR, et al
    Recurrent cholangitis in a 65-year-old man.
    Gut. 2014 Dec 22. pii: gutjnl-2014-308726. doi: 10.1136/gutjnl-2014-308726.
    PubMed     Text format    

    September 2014
  60. RUEGER S, Bochud PY, Dufour JF, Mullhaupt B, et al
    Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Gut. 2014 Sep 11. pii: gutjnl-2014-306997. doi: 10.1136/gutjnl-2014-306997.
    PubMed     Text format     Abstract available

    Piecing together the key players of fibrosis in chronic hepatitis C: what roles do non-hepatic liver resident cell types play?
    Gut. 2014 Sep 8. pii: gutjnl-2014-307957. doi: 10.1136/gutjnl-2014-307957.
    PubMed     Text format    

    August 2014
  62. BEILFUSS A, Sowa JP, Sydor S, Beste M, et al
    Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently.
    Gut. 2014 Aug 18. pii: gutjnl-2014-307024. doi: 10.1136/gutjnl-2014-307024.
    PubMed     Text format     Abstract available

    July 2014
  63. FLORIMOND A, Chouteau P, Bruscella P, Le Seyec J, et al
    Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.
    Gut. 2014 Jul 25. pii: gutjnl-2013-305634. doi: 10.1136/gutjnl-2013-305634.
    PubMed     Text format     Abstract available

  64. MACHADO MV, Michelotti GA, Pereira TD, Boursier J, et al
    Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.
    Gut. 2014 Jul 22. pii: gutjnl-2014-307362. doi: 10.1136/gutjnl-2014-307362.
    PubMed     Text format     Abstract available

  65. ARNDT S, Wacker E, Dorn C, Koch A, et al
    Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
    Gut. 2014 Jul 10. pii: gutjnl-2014-306968. doi: 10.1136/gutjnl-2014-306968.
    PubMed     Text format     Abstract available

  66. LIM TH, Gane E, Moyes C, Borman B, et al
    Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Maori: results from a 28-year follow-up study.
    Gut. 2014 Jul 8. pii: gutjnl-2013-306247. doi: 10.1136/gutjnl-2013-306247.
    PubMed     Text format     Abstract available

    May 2014
  67. MEJIAS M, Coch L, Berzigotti A, Garcia-Pras E, et al
    Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.
    Gut. 2014 May 21. pii: gutjnl-2014-307138. doi: 10.1136/gutjnl-2014-307138.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.